Log in to save to my catalogue

Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors

Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1566849312

Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors

About this item

Full title

Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors

Publisher

Boston: Springer US

Journal title

Journal of neuro-oncology, 2014-09, Vol.119 (2), p.343-351

Language

English

Formats

Publication information

Publisher

Boston: Springer US

More information

Scope and Contents

Contents

Osteopontin (OPN) is a protein linked to tumor growth, progression and metastasis of cancers. However, its role in the progression of central nervous system (CNS) embryonal tumors such as atypical teratoid/rhabdoid tumor (AT/RT), medulloblastoma (MB) and primitive neuroepithelial tumors (PNET) remains elusive. In this study, we investigated the val...

Alternative Titles

Full title

Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1566849312

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1566849312

Other Identifiers

ISSN

0167-594X

E-ISSN

1573-7373

DOI

10.1007/s11060-014-1484-4

How to access this item